Bruno Gomes

Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate

Stefano Crosignani, Patrick Bingham, Pauline Bottemanne et al. · Journal of Medicinal Chemistry · 2017 · 134 citations · Full text

Static lung storage at 10°C maintains mitochondrial health and preserves donor organ function

Aadil Ali, Aizhou Wang, Rafaela Vanin Pinto Ribeiro et al. · Science Translational Medicine · 2021 · 117 citations

Melanoma Chemotherapy Leads to the Selection of ABCB5-Expressing Cells

Marine Chartrain, Joëlle Riond, Aline Stennevin et al. · PLoS ONE · 2012 · 109 citations · Full text

Tumor Biology, Abcb5-expressing Cells, Oncology +12

Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma

Laurent Créancier, Isabelle Vandenberghe, Bruno Gomes et al. · Cancer Letters · 2015 · 90 citations

Ntrk1 Gene, Colorectal Cancer, Pathology +4

Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy

Bruno Gomes, Grégory Driessens, Derek W. Bartlett et al. · Molecular Cancer Therapeutics · 2018 · 83 citations · Full text